His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block

Ahran D Arnold1, Matthew J Shun-Shin1, Daniel Keene1

  • 1National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Insights

His bundle pacing offers superior ventricular resynchronization and hemodynamic improvement compared to biventricular pacing for cardiac resynchronization therapy (CRT). This novel approach enhances patient outcomes by optimizing cardiac function.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • His bundle pacing is an emerging technique for cardiac resynchronization therapy (CRT).
  • Conventional biventricular CRT is a standard treatment for heart failure patients with left bundle branch block.

Purpose of the Study:

  • To directly compare the efficacy of His bundle pacing against conventional biventricular pacing.
  • To assess the impact of His bundle pacing on ventricular activation and acute hemodynamic function.

Main Methods:

  • A head-to-head, acute crossover study was conducted in patients undergoing CRT.
  • Noninvasive epicardial electrocardiographic imaging identified suitable candidates for His bundle pacing.
  • Hemodynamic effects and ventricular activation were compared using a high-precision, repeated alternation protocol.

Main Results:

  • His bundle pacing significantly shortened left ventricular activation time in 18 of 23 patients.
  • Compared to biventricular pacing, His bundle pacing resulted in greater reductions in QRS duration, left ventricular activation time, and dyssynchrony index.
  • His bundle pacing demonstrated a superior acute hemodynamic response (4.6 mm Hg increase in cardiac output).

Conclusions:

  • His bundle pacing provides superior ventricular resynchronization compared to biventricular pacing.
  • This method leads to greater improvements in hemodynamic parameters.
  • His bundle pacing represents a promising advancement in cardiac resynchronization therapy.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312